Free Live Online Masterclass RWE & Trials with Professor Stuart Pocock THE VALUE OF HIERARCHICAL COMPOSTE ENDPOINTS AND THE WIN RATIO: Experience in Clinical Trials and extension to Real World DATE: Wednesday, 22 January 2025, at 5pm CEST | 4pm UK time | 11am EST. Join Professor Stuart Pocock—one of the world’s leading experts in…
Read more
Free Live Online Masterclass RWE & Trials with Professor Stuart Pocock “External Controls for Trials: Strategy, Science, Regulators & HTAs” DATE: Tuesday, 11 June 2024, at 5pm CEST | 4pm UK time | 11am EST. Free Live Online Masterclass to learn about perspectives on external controls from an epidemiologist/clinician and eminent medical statistician, illustrated with…
Read more
OXON’s Free Live Masterclass Series on Understanding Healthcare for RW Studies Session 4 – GERMANY: How to ensure success of your RWE studies and avoid pitfalls Learn about the healthcare system in Gemany, how medicine is practised, and get practical knowledge and advice to apply to your next observational study for safety, HEOR/market access, drug…
Read more
OXON’s Free Live Masterclass Series on Understanding Healthcare for RW Studies Session 2 – France: How to ensure success of your RWE studies and avoid pitfalls An understanding of the healthcare system in France and how medicine is practised within its context. In 60 minutes, get practical knowledge and advice to apply to your next…
Read more
OXON’s Free Live Masterclass Series on Understanding Healthcare for RW Studies Session 1 – THE UK: How to ensure success of your RWE studies and avoid pitfalls An understanding of the healthcare system in the UK and how medicine is practised within its context. In 60 minutes, get practical knowledge and advice to apply to…
Read more
OXON’s Free Live Masterclass Series on Understanding Healthcare for RW Studies Session 3 – ITALY: How to ensure success of your RWE studies and avoid pitfalls Learn about the healthcare system in Italy, how medicine is practised, and get practical knowledge and advice to apply to your next observational study for safety, HEOR/market access, drug…
Read more
RWE STUDIES & TRIALS FREE LIVE MASTERCLASS SERIES 2021 Session 1 – Non-randomized Comparative Effectiveness Studies: ‘The magic of randomization and the reality of Real-World Evidence’ Non-randomized comparative effectiveness studies may be conducted as a condition of new product approval, as well as to demonstrate benefits in under-studied populations and compare benefits from different products.…
Read more
RWE STUDIES & TRIALS FREE LIVE MASTERCLASS SERIES 2021 Session 4 – Individualizing Benefit-Risk Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would benefit identification of patients for treatment and help eligibility for future trials and RWE…
Read more
RWE STUDIES & TRIALS FREE LIVE MASTERCLASS SERIES 2021 Session 2 – The Tyranny of Propensity Scores: The Good and The Bad Almost every non-randomized comparative study is expected to consider analysis using propensity scores. However, are they always the best solution to address selection bias? In what circumstances are certain propensity scores techniques better…
Read more
RWE STUDIES & TRIALS FREE LIVE MASTERCLASS SERIES 2021 Session 3 – Non-randomized Comparative Safety Studies Approval of new drugs is often conditional on data collection and secondary data PASS studies. DATE:Wednesday, 19 May 2021 at 5pm CET | 4pm UK | 11am EDT | 8am PST TOPICS: Pros and cons of non-randomized studies of…
Read more
